Trial Profile
Phase 1a trial of CC-122 for relapsed-refractory diffuse large B cell lymphoma and non-Hodgkin's lymphoma
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 26 Apr 2018
Price :
$35
*
At a glance
- Drugs Avadomide (Primary)
- Indications Diffuse large B cell lymphoma; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 26 Apr 2018 New trial record